Taipei, Monday, December 18, 2017 03:48 (GMT+8)
cloudy
Taipei
14°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • Apex Biotechnology
  • Performance
    The company's stock price closed at NT$31.85 on the TSE on Thursday, December 14, 2017.
    The company has reported consolidated revenues of NT$143 million for November 2017, representing a 17.7% drop on month and 3.2% increase on year.
    For the third quarter of 2017, the company totaled NT$478 million in consolidated revenues, up 14% sequentially and up 18.7% on year.
    Brief

    Full name: Apex Biotechnology

    Chinese name: 五鼎生物技術股份有限公司

    Short name: Apex

    Stock code: 1733

    Tax ID: 16130182

    Market: TSE

    Established: 2 Dec 1997

    Paid in capital: NT$985.31 million

    Listed on TSE: 17 Sep 2001

    Website: www.apexbio.com

  • Latest stock
    Apex [1733] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    15-Dec 65 49 2,071,054 31.90 31.90 31.70 31.70-0.15-0.47% 31.70 31.85
    14-Dec 175 115 5,598,812 31.90 32.30 31.85 31.85-0.05-0.16% 31.85 32.00
    13-Dec 67 55 2,141,378 32.00 32.00 31.80 31.90+0.00+0.00% 31.85 31.90
    12-Dec 99 62 3,151,400 31.90 31.95 31.75 31.90+0.00+0.00% 31.80 31.95
    11-Dec 86 70 2,743,909 32.10 32.10 31.90 31.90-0.10-0.31% 31.90 31.95
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Nov 2016 - Nov 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Nov-17

    143

    (17.7%)

    3.2%

    1,639

    (1.7%)

    Oct-17

    173

    12.6%

    28.8%

    1,496

    (2.1%)

    Sep-17

    154

    5.4%

    17.5%

    1,323

    (5.1%)

    Aug-17

    146

    (18.4%)

    19.3%

    1,169

    (7.4%)

    Jul-17

    179

    16.7%

    19.1%

    1,024

    (10.3%)

    Jun-17

    153

    17.6%

    (4.5%)

    845

    (14.8%)

    May-17

    130

    (4.6%)

    (21.7%)

    692

    (16.7%)

    Apr-17

    136

    (22.2%)

    (25.2%)

    561

    (15.5%)

    Mar-17

    175

    77.6%

    (6.2%)

    425

    (11.8%)

    Feb-17

    99

    (34.6%)

    (25.8%)

    250

    (15.4%)

    Jan-17

    151

    27.1%

    (6.9%)

    151

    (6.9%)

    Dec-16

    119

    (14%)

    (14%)

    1,786

    (3.4%)

    Nov-16

    138

    2.8%

    (16.2%)

    1,667

    (2.5%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2017

    Apex: Consolidated revenues, 3Q16 - 3Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-17

    478

    14%

    18.7%

    1,323

    (5.1%)

    2Q-17

    420

    (1.2%)

    (17.5%)

    845

    (14.8%)

    1Q-17

    425

    15.2%

    (11.8%)

    425

    (11.8%)

    4Q-16

    369

    (8.5%)

    (23.1%)

    1,763

    (4.6%)

    3Q-16

    403

    (20.8%)

    (14.3%)

    1,394

    1.9%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    Current assets

    1,576,999

    1,632,388

    1,647,085

    1,602,788

    1,783,928

    Intangible assets

    304,638

    314,386

    25,010

    25,854

    26,609

    Non-current assets

    1,124,705

    1,143,758

    880,663

    897,998

    1,075,070

    Assets

    2,701,704

    2,776,146

    2,527,748

    2,500,786

    2,858,998

    Current liabilities

    1,062,660

    818,230

    482,436

    414,574

    642,761

    Non-current liabilities

    17,492

    355,661

    354,649

    353,912

    355,451

    Liabilities

    1,080,152

    1,173,891

    837,085

    768,486

    998,212

    Stockholders' equity

    1,621,552

    1,602,255

    1,690,663

    1,732,300

    1,860,786

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2017

    Apex: Consolidated income statement, 3Q16 - 3Q17 (NT$k)

    Item

    3Q-2017

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

    478,449

     

    419,801

     

    424,990

     

     

     

    403,241

     

    Operating revenue

    478,449

    100%

    419,801

    100%

    424,990

    100%

    368,972

    91.5%

    403,241

    100%

    Gross profit (loss) from operations

    102,951

    21.5%

    89,252

    21.3%

    75,548

    17.8%

    89,255

    22.1%

    91,021

    22.6%

    Operating expenses

    77,552

    16.2%

    47,662

    11.4%

    60,894

    14.3%

    56,217

    13.9%

    55,379

    13.7%

    Operating income (loss)

    25,399

    5.3%

    41,590

    9.9%

    14,654

    3.4%

    33,038

    8.2%

    35,642

    8.8%

    Non-operating expenses and losses

    3,629

    0.8%

    19,106

    4.6%

    -53,646

    -12.6%

    -144,637

    -35.9%

    -34,016

    -8.4%

    Income from continuing operations before income tax

    29,028

    6.1%

    60,696

    14.5%

    -38,992

    -9.2%

    -111,599

    -27.7%

    1,626

    0.4%

    Net income (loss)

    20,501

    4.3%

    57,277

    13.6%

    -38,992

    -9.2%

    -130,469

    -32.4%

    1,245

    0.3%

    Diluted earnings per share (NT$)

    0.2

     

    0

     

     

     

    0

     

    0

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2017

  • Apex Biotechnology full profile

15-Dec-2017 markets closed

 LastChange

TAIEX (TSE)10491.44-46.57-0.44% 

TSE electronic438.56-2.38-0.54% 

GTSM (OTC)145.8-0.46-0.31% 

OTC electronic220.42-0.82-0.37% 

UMC
China AMOLED panel capacity expansion forecast, 2016-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • Qualcomm royalty row

    Qualcomm faces pressure to renegotiate royalty terms with clients as more phone vendors reportedly mull following Apple's lead in suspending payments...

  • TSMC 3nm fab

    TSMC will build its 3nm fab in southern Taiwan.

  • SEMICON Taiwan 2017

    Semiconductor equipment and material suppliers are showcasing their latest products and technologies at SEMICON Taiwan 2017 in Taipei September 13-15.

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Taiwan server shipment forecast and industry analysis, 2017

    Digitimes Research estimates that revenues from sales of server motherboards, servers, storage systems and related network system equipment by Taiwan-based vendors reached NT$555.8 billion in 2016 and the amount is estimated to grow 5.9% on year in 2017.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.